abstract |
The present invention relates to the field of medicinal chemistry, and relates to an ethylenediamine compound represented by formula A, pharmaceutically acceptable salts, stereoisomers, tautomers or isomer mixtures thereof, hydrates thereof, solvates thereof, or prodrugs thereof, and use thereof in the treatment of tuberculosis. (A) |